74.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MIRM Giù?
Forum
Previsione
Precedente Chiudi:
$73.62
Aprire:
$74.88
Volume 24 ore:
2.10M
Relative Volume:
3.20
Capitalizzazione di mercato:
$3.73B
Reddito:
$379.25M
Utile/perdita netta:
$-77.34M
Rapporto P/E:
-46.06
EPS:
-1.6122
Flusso di cassa netto:
$-27.87M
1 W Prestazione:
+1.53%
1M Prestazione:
+3.83%
6M Prestazione:
+57.93%
1 anno Prestazione:
+90.51%
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Nome
Mirum Pharmaceuticals Inc
Settore
Industria
Telefono
650-667-4085
Indirizzo
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Confronta MIRM con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MIRM
Mirum Pharmaceuticals Inc
|
74.26 | 3.70B | 379.25M | -77.34M | -27.87M | -1.6122 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-11 | Ripresa | Stifel | Buy |
2025-05-19 | Ripresa | H.C. Wainwright | Buy |
2024-04-17 | Iniziato | Stifel | Buy |
2023-12-18 | Reiterato | H.C. Wainwright | Buy |
2023-11-20 | Ripresa | JP Morgan | Overweight |
2023-11-13 | Iniziato | Morgan Stanley | Overweight |
2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
2023-10-17 | Ripresa | Evercore ISI | Outperform |
2023-09-20 | Iniziato | JMP Securities | Mkt Outperform |
2022-09-01 | Iniziato | Citigroup | Buy |
2021-09-20 | Iniziato | JP Morgan | Overweight |
2020-08-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2020-08-03 | Iniziato | H.C. Wainwright | Buy |
2020-07-31 | Iniziato | Piper Sandler | Overweight |
2020-06-25 | Iniziato | Robert W. Baird | Outperform |
2019-08-12 | Iniziato | Citigroup | Buy |
2019-08-12 | Iniziato | Evercore ISI | Outperform |
2019-08-12 | Iniziato | Guggenheim | Buy |
2019-08-12 | Iniziato | ROTH Capital | Buy |
2019-08-12 | Iniziato | Raymond James | Outperform |
Mostra tutto
Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie
Mirum stock is a new Buy at TD Cowen (MIRM:NASDAQ) - Seeking Alpha
TD Cowen initiates coverage on Mirum Pharmaceuticals stock with Buy rating - Investing.com
CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - sharewise.com
Contravisory Investment Management Inc. Acquires Shares of 5,307 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo
Atle Fund Management AB Grows Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
12,200 Shares in Mirum Pharmaceuticals, Inc. $MIRM Bought by Strs Ohio - MarketBeat
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Recap: Should I hold or sell Mirum Pharmaceuticals Inc nowPortfolio Update Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Bond Watch: What is Mirum Pharmaceuticals Inc. s debt to equity ratioMarket Growth Summary & Pattern Based Trade Signal System - khodrobank.com
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $74.44 Consensus Target Price from Brokerages - MarketBeat
Investment Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesProduct Launch & Technical Pattern Alert System - خودرو بانک
Retail Trends: Is Springview Holdings Ltd showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Millennium Management LLC - MarketBeat
Risk Report: Will Mirum Pharmaceuticals Inc benefit from AI trends2025 Market Overview & Precise Swing Trade Alerts - خودرو بانک
Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Citizens JMP reiterates Market Outperform rating on Mirum Pharmaceuticals stock - Investing.com Canada
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by Rhumbline Advisers - Defense World
JPMorgan Chase & Co. Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price - MarketBeat
Activity Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesJuly 2025 Closing Moves & Consistent Return Investment Signals - خودرو بانک
Trade Report: Can Mirum Pharmaceuticals Inc. deliver consistent dividendsMarket Volume Summary & Free Community Consensus Stock Picks - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Holdings Increased by Woodline Partners LP - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Investing News Network
Mirum Pharma director Brege sells $1.26m in shares - Investing.com India
Mirum Pharma director Brege sells $1.26m in shares By Investing.com - Investing.com Canada
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $77 - 富途牛牛
Adage Capital Partners GP L.L.C. Purchases 195,000 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Saira Ramasastry, Mirum director, sells $1.3m in shares By Investing.com - Investing.com Canada
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighHere's Why - MarketBeat
Eventide Asset Management LLC Sells 79,938 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals at Morgan Stanley Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Mirum Pharmaceuticals announces enrollment completion in the phase 2b Vistas study - MarketScreener
Published on: 2025-09-08 12:42:47 - beatles.ru
Northern Trust Corp Decreases Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
Is Mirum Pharmaceuticals Inc. stock overvalued or fairly priced2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
PDT Partners LLC Has $6.19 Million Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. forming bullish engulfing patternsEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Can Mirum Pharmaceuticals Inc. reach resistance levels soon2025 EndofYear Setup & Fast Gain Swing Alerts - خودرو بانک
Real time scanner hits for Mirum Pharmaceuticals Inc. explainedBond Market & AI Driven Stock Movement Reports - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. forming a reversal patternPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-05 14:03:50 - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Rafferty Asset Management LLC Raises Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. stock recover after recent dropMarket Movement Recap & Detailed Earnings Play Alerts - Newser
Using Ichimoku Cloud for Mirum Pharmaceuticals Inc. technicalsQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
Mirum Pharmaceuticals Inc Azioni (MIRM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):